postoperative follow-up duration or other factors were related to the subjective cure rate. Results: Eight cases of TVT and 59 cases of TVT-O completed the follow-up. Patients were followed up for 1.3-12 years in TVT and 0.2-9.2 years in TVT-O group. The rates of subjectively assessed success were 87.5% and 84.7%, respectively (P=1.00). The total KHQ were (21.93±30.42) and (16.89±25.85) (P=0.55). The operation duration were (59.29±21.02) in TVT group and (29.87±12.04) in TVT-O group (P=0.00). The postoperative days of indwelling catheter were (4.14±1.79) and (3.11±1.51) (P=0.02), and the post-operation hospitalization days were (5.64±2.06) and (5.01±1.77) (P=0.27). The factors above didn't affect the subjective cure rate.
AB195. Correlations among improvements in overactive bladder symptom scores (OABSS) and urinary nerve growth factor levels in overactive bladder patients
Bo Yang
Department of urology, Xijing Hospital, the Fourth Military Medical University, Xian 710032, China Objective: To investigate whether the urinary nerve growth factor (NGF) levels in overactive bladder (OAB) patients is related to the improvement of overactive bladder symptom scores (OABSS) and quality of life index, following treatment of anti-muscarinic agent. Methods: Forty-seven patients suffered from OAB and twenty normal controls were included in this study. An antimuscarinic agent (solifenacin succinate 5 mg once a day) was administered for the OAB patients. At enrolment and after 12 weeks of treatment, the OABSS and the quality of life (QOL) score were determined. The urinary NGF/Cr level was also examined. Results: The urinary NGF/Cr level was higher in the OAB patients than in the controls in baseline (P<0.05). After 12 weeks treatment with anti-muscarinic agent, the OABSStotal and QOL scores were all significantly decreased (P<0.001 each) in the OAB-dry and OAB-wet patients. And the urinary NGF/Cr levels decreased in OAB-wet patients, but not in OAB-dry patients. Furthermore, treatmentrelated changes of urinary NGF/Cr levels were correlated well with changes in four OABSS subscales (which include daytime voiding, nighttime voiding, urgency, and urge incontinence) (P<0.001) and QOL score (P<0.001) in only OAB-wet patients, but not in OAB-dry patients. Conclusions: Improvement of OAB symptoms and QOL by treatment with the anti-muscarinic agent was related to the decrease of urinary NGF/Cr level in the OAB-wet patients, but not in OAB-dry patients. Therefore, NGF/Cr level as biomarkers for assessing therapeutic outcome of OAB should be interpreted with caution. 
